NSE · PANACEABIO
Panacea Biotec Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,158
of 5,004 stocks
🏆 New peak
▲ 131W
Peak #1,158 · 01 Oct 2026
Panacea Biotec Limited is a smallcap company in the Healthcare space and has a subdued return on equity, remains firmly promoter-controlled, with promoters holding 72%, and is growing revenue at a solid clip.
Market Cap
2,243.58 Cr
P/E Ratio
—
P/B Ratio
2.71
ROE
-0.86%
ROCE
-2.28%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 199.57 Cr | 166.75 Cr | 165.19 Cr | 141.13 Cr |
| Net Profit | 2.20 Cr | -1.00 Cr | 3.89 Cr | -14.01 Cr |
| EPS | 0.38 | 0.08 | 0.65 | -2.27 |
| Operating Profit | 2.01 Cr | -2.76 Cr | 5.57 Cr | -19.73 Cr |
Shareholding pattern
Promoter
72.48%
Public
27.52%
PUBLIC BREAKDOWN
FII
2.31%
DII
2.25%
MF (within DII)
0.00%
Individuals
16.73%
Mutual fund holdings
₹0.03
Cr total
2
Schemes
2
Fund Houses
₹0.03 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.02 Cr (65.2%)
Bandhan Mutual Fund₹0.01 Cr (34.8%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 19 Sep 2024 | Other | Annual General Meeting |
| 21 Sep 2023 | Other | Annual General Meeting |
| 19 Sep 2022 | Other | Annual General Meeting |
| 16 Sep 2021 | Other | Annual General Meeting |
| 15 Dec 2020 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.